‘When these patients come, tested their tumors positive for estrogen receptors, so they began on anti-estrogen treatment well with the idea that they do. Yet these tumors not on estrogen at all related for growth and will continue to grow during therapy. Robust robust way such tumors such tumors soon after diagnosis. ‘.. Previously , doctors had no way to know these tumors would be unresponsive because their pathology is deceptive the tumors appear to be more easily treatable estrogen – receptor-positive tumors, but they quickly their estrogen receptors.
The researchers presented findings 2nd June at 10.45 clock in CT at the 2008 American Society of Clinical Oncology Annual Meeting in Chicago. ‘We were interested in how to relapse in patients with estrogen – receptor positive breast cancer predict,’Ellis says. ‘So we have for the genetic expression profiles associated with relapse, but we have a very different approach from previous studies that addressed this issue. ‘.Underlie to vulvar cancer report through additional Screens of EGFR genes.
Although cancer of vulva – women structure exernal genital – is rare, it is often recurs after standard treatment, and little bit about factors which announced to its development change in. Expression or activity of EGFR with lots solid tumors and cancers have patients who EGFR mutations of many times succeed taken with medications that control at the molecular mechanism of the receptor treating compound. The study , which was released line , is designed order to investigate whether EGFR activity be in in of the vulva tumors.